歌礼制药有限公司（01672）于2026年2月10日发布翌日披露报表，披露新股发行及回购股份拟注销等事项。公告显示，公司在2026年2月10日根据一般授权配发及发行69,256,000股新股份，占期初已发行股本（不含库藏股）约6.98%，每股发行价为12.18港元。发行完成后，公司已发行股本由991,874,320股增至1,061,130,320股，库藏股维持7,084,210股，总股本变动为1,068,214,530股。
此外，公司披露2025年4月至12月期间多次回购股份，累计回购5,786,000股，价格区间介乎每股4.8531港元至14.5794港元，上述股份暂未注销。公司确认已遵守香港联合交易所有限公司证券上市规则及其他适用法律法规。
本公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.